Allied Healthcare Products (Allied Healthcare Products) Long-Term Capital Lease Obligation

: $0.00 Mil (As of Jun. 2022)

View and export this data going back to 1992. Start your Free Trial

Allied Healthcare Products's Long-Term Capital Lease Obligation for the quarter that ended in Jun. 2022 was $0.00 Mil.

Allied Healthcare Products's quarterly Long-Term Capital Lease Obligation declined from Dec. 2021 ($0.01 Mil) to Mar. 2022 ($0.00 Mil) and declined from Mar. 2022 ($0.00 Mil) to Jun. 2022 ($0.00 Mil).

Allied Healthcare Products's annual Long-Term Capital Lease Obligation declined from Jun. 2020 ($0.01 Mil) to Jun. 2021 ($0.01 Mil) and declined from Jun. 2021 ($0.01 Mil) to Jun. 2022 ($0.00 Mil).

Allied Healthcare Products Long-Term Capital Lease Obligation Historical Data

The historical data trend for Allied Healthcare Products's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allied Healthcare Products Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.01

Allied Healthcare Products Quarterly Data
	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.01	0.01	0.01	-	-

Allied Healthcare Products (OTCPK:AHPIQ) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Allied Healthcare Products Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Allied Healthcare Products's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Allied Healthcare Products (Allied Healthcare Products) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allied Healthcare Products Inc (OTCPK:AHPIQ) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

1720 Sublette Avenue, Saint Louis, MO, USA, 63110

Website

https://www.alliedhpi.com

Allied Healthcare Products Inc manufactures a variety of respiratory products used in the healthcare industry in a wide range of hospital and alternate site settings, including sub-acute care facilities, home health care, and emergency medical care. The product line of the company includes respiratory anesthesia products, home respiratory care products, medical gas system construction products, medical gas system regulation devices, disposable oxygen, and specialty gas cylinders, portable suction equipment, trauma, and patient handling products, respiratory products, and others. The company markets its products under various brand names Timeter, Carbolime, Litholyme, Schuco, Chemetron, Oxequip, Lif-O-Gen, Gomco, and others.

Executives

John D Weil	director, 10 percent owner	10 S. BROADWAY, SUITE 2000, ST LOUIS MO 63102
Susan M Deuser	director	1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Kevin D Kroupa	officer: Vice President of Operations	1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Earl R Refsland	director, officer: President and CEO	1720 SUBLETT AVENUE, ST. LOUIS MO 63110
Joseph F Ondrus	officer: Vice President of Operations	1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Andrew Riley	officer: VP of Operations	1720 SUBLETTE AVE., ST. LOUIS MO 63110
William A Peck	director	35 CROSBY DRIVE, BEDFORD MA 01730
Daniel C Dunn	officer: VP - Finance and CFO	1720 SUBLETTE AVE, ST. LOUIS MO 63110
Eldon P Rosentrater	officer: VP - Administration	1720 SUBLETTE AVE, ST. LOUIS MO 63110
Root Joseph Ernest Jr	director	HAYNES BEFFEL & WOLFELD LLP, 751 KELLY STREET, HALF MOON BAY CA 94019
Robert Bradley Harris	officer: Vice President of Operations	15 RIVER RIDGE TRAIL, ORMOND BEACH FL 32174
Judy T Graves	director	13317 WESTERMAN RD, ST LOUIS MO 63122
Hickey James B Jr	director	4608 EDINA BLVD, EDINA MN 55424
Richard A Setzer	officer: VICE PRESIDENT SALES & MKTG	1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Brent D Baird	director	1350 ONE M&T PLAZA, BUFFALO NY 14203-2396